Yu Dong
Nagoya, 4678601, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Discovering novel mechanisms of taxane resistance in human breast cancer by whole-exome sequencing.
Journal: Oncology letters
Published: April 08, 2021
Low RAI2 expression is a marker of poor prognosis in breast cancer.
Journal: Breast cancer research and treatment
Published: May 16, 2020
Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients.
Journal: Japanese journal of clinical oncology
Published: November 02, 2018
Effects of serum estradiol and progesterone on estrogen-regulated gene expression in breast cancers of premenopausal patients.
Journal: Japanese journal of clinical oncology
Published: July 11, 2018
HER2 mutation status in Japanese HER2-positive breast cancer patients.
Journal: Breast cancer (Tokyo, Japan)
Published: August 25, 2015
Prognostic impact of a single-nucleotide polymorphism near the CTSO gene in hormone receptor-positive breast cancer patients.
Journal: International journal of clinical oncology
Published: July 17, 2015
High expression of LMTK3 is an independent factor indicating a poor prognosis in estrogen receptor α-positive breast cancer patients.
Journal: Japanese journal of clinical oncology
Published: August 29, 2014
Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer.
Journal: BMC cancer
Published: July 01, 2014
HER2 mutation status in Japanese HER2-negative breast cancer patients.
Journal: Japanese journal of clinical oncology
Published: May 08, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026